CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 76 filers reported holding CUE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $196,000 | -51.8% | 40,070 | +14.7% | 0.01% | -73.5% |
| Q2 2021 | $407,000 | +31.7% | 34,935 | +37.9% | 0.03% | +21.4% |
| Q1 2021 | $309,000 | +42.4% | 25,334 | +46.2% | 0.03% | +21.7% |
| Q4 2020 | $217,000 | +1.4% | 17,332 | +21.9% | 0.02% | +64.3% |
| Q3 2020 | $214,000 | -46.1% | 14,222 | -12.2% | 0.01% | -50.0% |
| Q2 2020 | $397,000 | +128.2% | 16,193 | +31.8% | 0.03% | +115.4% |
| Q1 2020 | $174,000 | – | 12,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |